EUVIMEDScopri EUVIMED
Open access

Cryptotanshinone Directly Targets MEK1 to Inhibit Migration and Invasion of Breast Cancer Cells Through Down‐Regulating ERK / EMT Axis

Min Qian, Xin Liu, Zhuoran Chai, Mengyao Li, Xiaoxiao Wang, Jiahui Du, Shuhui You, Min Xiang, Xin Ju, Liangzhi Li, Yuyang Zhou, Songbai Liu and 2 more

Phytotherapy Research · 2026

DOI: 10.1002/ptr.70395 ↗

At a glance

Journal article in Phytotherapy Research, 2026. Written by Min Qian and 13 co-authors. Institution: School of Chemistry and Life Science, Suzhou University of Science and Technology, Suzhou, China. Major MEDLINE topics: Phenanthrenes, Cell Movement, Epithelial-Mesenchymal Transition, Breast Neoplasms. 44 references. The full text is freely available in PubMed Central. Funded by: Foundation for Innovative Research Groups of the National Natural Science Foundation of China, the Natural Science Foundation of Jiangsu Province, Minsheng Science and Technology Project of Suzhou.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Cryptotanshinone (CPT) exerts inhibitory effects on breast cancers (BC). However, its effect and potential mechanism on breast cancer cell migration and invasion are not well understood. This study aims to investigate the potential mechanism of CPT on migration and invasion by network pharmacology and experiments. Wound healing and Transwell Matrigel invasion assays were performed to analyze the effects of CPT on migration and invasion in breast cancer cell lines MCF‐7 and 4 T1. Western blot and immunofluorescence analyses were performed to verify the effect of CPT on epithelial‐mesenchymal transition (EMT). Network pharmacology and experiments were used to explore the potential mechanism of CPT on EMT in breast cancer. Molecular docking, molecular dynamics (MD) simulation, cellular thermal shift assays (CETSA), drug affinity responsive target stability (DARTS), transfection, and mutagenesis were performed to confirm the direct binding effect of CPT on MEK1. Finally, BC nude mouse xenografts were established to explore the anti‐metastasis effect of CPT in vivo. We found that CPT inhibited the EMT process to attenuate the migration and invasion of BC cells in a dose‐dependent manner. Subsequently, network pharmacology, CETSA, DARTS, and enzyme activity assays confirmed that CPT directly binds MEK1 to inhibit its phosphorylation and kinase activity. Moreover, the molecular docking, MD, and mutagenesis results showed that CPT bound to MEK1 at Gly80 and Asp208. Moreover, MEK inhibitor (AZD‐6244) intervention studies confirmed that CPT inhibits EMT by targeting the MEK pathway. Finally, the mouse tail vein injection model showed that CPT can effectively inhibit BC metastasis in vivo. Our results demonstrated that CPT modulates breast cancer migration and invasion via the MEK/ERK/EMT axis by directly targeting MEK1. Our study provides evidence suggesting that CPT may serve as a potential agent for suppressing breast cancer metastasis.

Subjects

MeSH terms (MEDLINE)

PhenanthrenesCell MovementEpithelial-Mesenchymal TransitionBreast NeoplasmsMAP Kinase Kinase 1HumansFemaleAnimalsMice, NudeMiceMolecular Docking SimulationNeoplasm InvasivenessDown-RegulationCell Line, TumorMCF-7 CellsMice, Inbred BALB CXenograft Model Antitumor AssaysMAP Kinase Signaling System

Author keywords

MEK1cryptotanshinoneepithelial‐to‐mesenchymal transitioninvasionmigration

Substances

PhenanthrenescryptotanshinoneMAP Kinase Kinase 1MAP2K1 protein, human

Authors and institutions

  • School of Chemistry and Life Science, Suzhou University of Science and Technology, Suzhou, China.
  • School of Medicine, Suzhou Vocational Health College, Suzhou, China.
  • Jiangsu Province Engineering Research Center of Molecular Target Therapy and Companion Diagnostics in Oncology, Suzhou Vocational Health College, Suzhou, China.
  • School of Medicine, Zhengzhou University, Zhengzhou, China.

ORCID profiles: Weiqiang Guo

Funding

  • Foundation for Innovative Research Groups of the National Natural Science Foundation of China
  • the Natural Science Foundation of Jiangsu Province
  • Minsheng Science and Technology Project of Suzhou
  • Jiangsu Provincial Engineering Research Center for Small Molecule Targeted Therapy and Companion Diagnosis of Tumors - Open Project
  • Natural Science Foundation of Jiangsu Province

Cite

APA

Qian, M., Liu, X., Chai, Z., Li, M., Wang, X., Du, J., You, S., Xiang, M., Ju, X., Li, L., Zhou, Y., Liu, S., Bi, Y., & Guo, W. (2026). Cryptotanshinone Directly Targets MEK1 to Inhibit Migration and Invasion of Breast Cancer Cells Through Down‐Regulating ERK / EMT Axis. Phytotherapy Research. https://doi.org/10.1002/ptr.70395

Vancouver

Qian M, Liu X, Chai Z, Li M, Wang X, Du J, et al. Cryptotanshinone Directly Targets MEK1 to Inhibit Migration and Invasion of Breast Cancer Cells Through Down‐Regulating ERK / EMT Axis. Phytotherapy Research. 2026. doi:10.1002/ptr.70395

BibTeX
@article{Qian2026,
  author = {Qian, Min and Liu, Xin and Chai, Zhuoran and Li, Mengyao and Wang, Xiaoxiao and Du, Jiahui and You, Shuhui and Xiang, Min and Ju, Xin and Li, Liangzhi and Zhou, Yuyang and Liu, Songbai and Bi, Yuefeng and Guo, Weiqiang},
  title = {Cryptotanshinone Directly Targets MEK1 to Inhibit Migration and Invasion of Breast Cancer Cells Through Down‐Regulating ERK / EMT Axis},
  journal = {Phytotherapy Research},
  year = {2026},
  doi = {10.1002/ptr.70395}
}
Start for free →